In this study, we have used the standardized methodology validated in breast cancer diagnostics.20 Our finding of similar expression of PR and CD3-positive T cells is consistent with previous studies showing no difference between LPV and control samples.3,8. The gene discussed is PGR; the disease is breast cancer.